Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5206472
Max Phase: Preclinical
Molecular Formula: C31H48N2O8
Molecular Weight: 576.73
Associated Items:
ID: ALA5206472
Max Phase: Preclinical
Molecular Formula: C31H48N2O8
Molecular Weight: 576.73
Associated Items:
Canonical SMILES: COC(=O)C[C@@H]1C[C@@]2(CO2)[C@H](O)[C@@H](/C=C/C(C)=C/C[C@@H]2O[C@H](C)[C@H](NC(=O)/C=C\[C@H](C)NC(=O)C(C)C)C[C@@H]2C)O1
Standard InChI: InChI=1S/C31H48N2O8/c1-18(2)30(37)32-21(5)10-13-27(34)33-24-14-20(4)25(40-22(24)6)11-8-19(3)9-12-26-29(36)31(17-39-31)16-23(41-26)15-28(35)38-7/h8-10,12-13,18,20-26,29,36H,11,14-17H2,1-7H3,(H,32,37)(H,33,34)/b12-9+,13-10-,19-8+/t20-,21-,22+,23+,24+,25-,26+,29+,31+/m0/s1
Standard InChI Key: AEKGVHIUIYKTFT-AYMDAWMLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 576.73 | Molecular Weight (Monoisotopic): 576.3411 | AlogP: 2.74 | #Rotatable Bonds: 11 |
Polar Surface Area: 135.72 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.92 | CX Basic pKa: | CX LogP: 2.23 | CX LogD: 2.23 |
Aromatic Rings: 0 | Heavy Atoms: 41 | QED Weighted: 0.15 | Np Likeness Score: 2.07 |
1. Ghosh AK, Mishevich JL, Jurica MS.. (2021) Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors., 84 (5.0): [PMID:33974423] [10.1021/acs.jnatprod.1c00100] |
Source(1):